These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 37204842)

  • 21. The T4/T3 quotient as a risk factor for differentiated thyroid cancer: a case control study.
    Sasson M; Kay-Rivest E; Shoukrun R; Florea A; Hier M; Forest VI; Tamilia M; Payne RJ
    J Otolaryngol Head Neck Surg; 2017 Apr; 46(1):28. PubMed ID: 28376913
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The diagnostic accuracy of ultrasound-guided fine-needle aspiration biopsy and the sonographic differences between benign and malignant thyroid nodules 3 cm or larger.
    Yoon JH; Kwak JY; Moon HJ; Kim MJ; Kim EK
    Thyroid; 2011 Sep; 21(9):993-1000. PubMed ID: 21834673
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Can Cytologic and Sonographic Features Help Prevent Overtreatment of Bethesda V Thyroid Nodules?
    Higgins S; James BC; Sacks B; Mowschenson P; Nishino M; Hasselgren PO
    J Surg Res; 2021 Dec; 268():112-118. PubMed ID: 34298210
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lack of association between high serum thyroid-stimulating hormone level and risk of papillary thyroid microcarcinomas.
    Sohn SY; Kim HJ; Jang HW; Kim SW; Chung JH
    Head Neck; 2014 Jan; 36(1):43-6. PubMed ID: 23728859
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Benign cytology does not rule out malignancy in thyroid nodules larger than 4 cm.
    Baser OO; Koseoglu D; Cetin Z; Catak M; Kizilkaya H
    Diagn Cytopathol; 2022 Nov; 50(11):508-512. PubMed ID: 36181431
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of serum thyroid-stimulating hormone as indicator for fine-needle aspiration in patients with thyroid nodules.
    Choi JS; Nam CM; Kim EK; Moon HJ; Han KH; Kwak JY
    Head Neck; 2015 Apr; 37(4):498-504. PubMed ID: 24435826
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preoperative Thyroid-Stimulating Hormone Levels and Risk of Thyroid Cancer in Post-thyroidectomy Patients for Thyroid Nodules: A Study From a Tertiary Hospital in Western Saudi Arabia.
    Al-Hakami HA; Altayyeb JF; Alsharif SM; Alshareef MA; Awad BI; Al-Garni M
    Cureus; 2023 Oct; 15(10):e47622. PubMed ID: 38022328
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preoperative serum thyroglobulin and changes in serum thyroglobulin during TSH suppression independently predict follicular thyroid carcinoma in thyroid nodules with a cytological diagnosis of follicular lesion.
    Kim HJ; Mok JO; Kim CH; Kim YJ; Kim SJ; Park HK; Byun DW; Suh K; Yoo MH
    Endocr Res; 2017 May; 42(2):154-162. PubMed ID: 27936964
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The clinical significance of the American College of Radiology (ACR) Thyroid Imaging Reporting and Data System (TI-RADS) category 5 thyroid nodules: Not as risky as we think?
    Wright K; Brandler TC; Fisher JC; Rothberger GD; Givi B; Prescott J; Suh I; Patel KN
    Surgery; 2023 Jan; 173(1):239-245. PubMed ID: 36511283
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum thyrotropin concentration as a novel predictor of malignancy in thyroid nodules investigated by fine-needle aspiration.
    Boelaert K; Horacek J; Holder RL; Watkinson JC; Sheppard MC; Franklyn JA
    J Clin Endocrinol Metab; 2006 Nov; 91(11):4295-301. PubMed ID: 16868053
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Does a higher American College of Radiology Thyroid Imaging Reporting and Data System (ACR TI-RADS) score forecast an increased risk of malignancy? A correlation study of ACR TI-RADS with FNA cytology in the evaluation of thyroid nodules.
    Modi L; Sun W; Shafizadeh N; Negron R; Yee-Chang M; Zhou F; Simsir A; Sheth S; Brandler TC
    Cancer Cytopathol; 2020 Jul; 128(7):470-481. PubMed ID: 32078249
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Malignancy rate in thyroid nodules classified as Bethesda category III (AUS/FLUS).
    Ho AS; Sarti EE; Jain KS; Wang H; Nixon IJ; Shaha AR; Shah JP; Kraus DH; Ghossein R; Fish SA; Wong RJ; Lin O; Morris LG
    Thyroid; 2014 May; 24(5):832-9. PubMed ID: 24341462
    [TBL] [Abstract][Full Text] [Related]  

  • 33. False-negative results with the Bethesda System of reporting thyroid cytopathology: predictors of malignancy in thyroid nodules classified as benign by cytopathologic evaluation.
    Richmond BK; Judhan R; Chong B; Ubert A; AbuRahma Z; Mangano W; Thompson S
    Am Surg; 2014 Aug; 80(8):811-6. PubMed ID: 25105404
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bethesda Category III, IV, and V Thyroid Nodules: Can Nodule Size Help Predict Malignancy?
    Kiernan CM; Solórzano CC
    J Am Coll Surg; 2017 Jul; 225(1):77-82. PubMed ID: 28223197
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A retrospective analysis of thyroid cancer in China.
    Yang Y; Li Q; Guo L; Cui M; Bao T; Zhang Z; Wang C; Ni Y; Zhang J
    Asian Pac J Cancer Prev; 2011; 12(9):2245-9. PubMed ID: 22296364
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fine needle aspiration of the thyroid: correlation with final histopathology in a surgical series of 797 patients.
    Lew JI; Snyder RA; Sanchez YM; Solorzano CC
    J Am Coll Surg; 2011 Jul; 213(1):188-94; discussion 194-5. PubMed ID: 21601489
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The impact of thyroid nodule size on the risk of malignancy in follicular neoplasms.
    Ibrahim Y; Mohamed SE; Deniwar A; Al-Qurayshi ZH; Khan AN; Moroz K; Friedlander P; Kandil E
    Anticancer Res; 2015 Mar; 35(3):1635-9. PubMed ID: 25750321
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cytological Sub-Classification of Atypia of Undetermined Significance May Predict Malignancy Risk in Thyroid Nodules.
    Elomami A; Elhag SA; Alseddeeqi E
    Acta Cytol; 2021; 65(3):205-212. PubMed ID: 33524971
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diagnostic Lobectomy for Bethesda III Thyroid Nodules: Pathological Outcomes and Risk Factors for Malignancy.
    Walters BK; Garrett SL; Aden JK; Williams GM; Butler-Garcia SL; Newberry TR; Mckinlay AJ
    Ann Otol Rhinol Laryngol; 2021 Sep; 130(9):1064-1068. PubMed ID: 33567896
    [TBL] [Abstract][Full Text] [Related]  

  • 40. One in four patients with follicular thyroid cytology (THY3) has a thyroid carcinoma.
    Mihai R; Parker AJ; Roskell D; Sadler GP
    Thyroid; 2009 Jan; 19(1):33-7. PubMed ID: 18976164
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.